Quintiles to buy BRI:
This article was originally published in Clinica
Executive Summary
Quintiles, a leading contract research organisation, is to acquire BRI International in a stock swap valued at $127 million. BRI earlier this year merged with Medical Technology Consultants Europe to create a global medical device consultancy, MTC-BRI International (see Clinica No 695, p 16). Under the terms of the agreement, all of BRI's stock would be exchanged for 1.9 million shares of Quintiles stock, which closed on July 30th at $67.